Pay - for - delay («PFD») agreements are agreements that are intended to delay the market entry of generic manufacturers with generic drugs in exchange for payments made by original pharmaceutical producers (i.e., holders of patents for
an original branded drug).
Not exact matches
The divestment would complete the company's gradual shift away from its
original focus on generic
drugs and nuclear imaging toward
branded specialty pharmaceuticals, which now comprise the bulk of its revenues.
The vast majority, 81, were generic versions of
brand - name
drugs on which Cetero scientists had often run critical tests to determine whether the copies did, in fact, act the same in the body as the
originals.
Prescription
drugs that are no longer patent - protected and are sold by
drug manufacturers under a different name than the
original brand name
drug.